Israel’s MetaSight Diagnostics is developing fast, low-cost mass spectrometry to perform vast amounts of serum biopsies of the metabolome (molecules in a cell). These can detect cancer, liver disease, cardiovascular and neurological diseases etc. MetaSight is working with KSM (Maccabi’s R&D).